ALAMEDA, Calif., Feb. 10 /PRNewswire-FirstCall/ -- Avigen, Inc. a biopharmaceutical company developing innovative therapies for the treatment of neurological conditions announced that it will be discussing its fourth quarter and full year 2005 results in a conference call at 9:00 am (Eastern time) on Thursday, February 16th, 2006. Ken Chahine, chief executive officer, and Michael Coffee, Chief Business Officer, can be heard by dialing 866-713-8562 (tollfree) in the U.S. or +1-617-597-5310 (toll) elsewhere. Conference ID 19679959
This call is also being webcast live and can be accessed at Avigen’s Web site at www.avigen.com.
For those who cannot listen to the live broadcast, a replay will be available shortly after the conference call on the link on the company’s website www.avigen.com or by dialing 888-286-8010 (tollfree) in the U.S. or +1-617-801-6888 (toll) elsewhere, and entering the access code 60707431.
For press releases and other corporate information, visit our website at www.avigen.com.
Avigen, Inc.
CONTACT: Michael Coffee, Chief Business Officer of Avigen, Inc.,+1-510-748-7372, or fax, +1-510-748-7384, or mcoffee@avigen.com
Web site: http://www.avigen.com/
